These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Endometrial Adenocarcinomas With Significant Mucinous Differentiation: A Characterization of Intratumoral Heterogeneity of KRAS Mutations in Mucinous and Endometrioid Histologic Components. Jackson CL; Hang S; Hansen K; He M; Sung CJ; Quddus MR; Xiong M; Wang Y; Patel NR; Lawrence WD; Xiong J Int J Gynecol Cancer; 2018 Feb; 28(2):241-247. PubMed ID: 29303928 [TBL] [Abstract][Full Text] [Related]
4. Endometrial carcinomas with significant mucinous differentiation associated with higher frequency of k-ras mutations: a morphologic and molecular correlation study. Xiong J; He M; Jackson C; Ou JJ; Sung CJ; Breese V; Steinhoff MM; Quddus MR; Tejada-Berges T; Lawrence WD Int J Gynecol Cancer; 2013 Sep; 23(7):1231-6. PubMed ID: 23851676 [TBL] [Abstract][Full Text] [Related]
5. The clinical significance of K-ras mutation in endometrial "surface epithelial changes" and their associated endometrial adenocarcinoma. Xiong J; He M; Hansen K; Jackson CL; Breese V; Quddus MR; Sung CJ; Lomme MM; Lawrence WD Gynecol Oncol; 2016 Jul; 142(1):163-168. PubMed ID: 27154241 [TBL] [Abstract][Full Text] [Related]
6. Frequent KRAS mutation in complex mucinous epithelial lesions of the endometrium. Alomari A; Abi-Raad R; Buza N; Hui P Mod Pathol; 2014 May; 27(5):675-80. PubMed ID: 24186144 [TBL] [Abstract][Full Text] [Related]
7. BRAF V600E Mutations in Endometrial Adenocarcinoma. He M; Breese V; Hang S; Zhang C; Xiong J; Jackson C Diagn Mol Pathol; 2013 Mar; 22(1):35-40. PubMed ID: 23370429 [TBL] [Abstract][Full Text] [Related]
8. Molecular profiles of benign and (pre)malignant endometrial lesions. van der Putten LJM; van Hoof R; Tops BBJ; Snijders MPLM; van den Berg-van Erp SH; van der Wurff AAM; Bulten J; Pijnenborg JMA; Massuger LFAG Carcinogenesis; 2017 Mar; 38(3):329-335. PubMed ID: 28203752 [TBL] [Abstract][Full Text] [Related]
9. KRAS Mutations in Mucinous Lesions of the Uterus. He M; Jackson CL; Gubrod RB; Breese V; Steinhoff M; Lawrence WD; Xiong J Am J Clin Pathol; 2015 Jun; 143(6):778-84. PubMed ID: 25972319 [TBL] [Abstract][Full Text] [Related]
10. BRAF mutation in endometrial carcinoma and hyperplasia: correlation with KRAS and p53 mutations and mismatch repair protein expression. Feng YZ; Shiozawa T; Miyamoto T; Kashima H; Kurai M; Suzuki A; Konishi I Clin Cancer Res; 2005 Sep; 11(17):6133-8. PubMed ID: 16144912 [TBL] [Abstract][Full Text] [Related]
11. Mutations of the KRAS oncogene in endometrial hyperplasia and carcinoma. Dobrzycka B; Terlikowski SJ; Mazurek A; Kowalczuk O; Niklińska W; Chyczewski L; Kulikowski M Folia Histochem Cytobiol; 2009; 47(1):65-8. PubMed ID: 19419940 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic application of KRAS mutation testing in uterine microglandular proliferations. Hong W; Abi-Raad R; Alomari AK; Hui P; Buza N Hum Pathol; 2015 Jul; 46(7):1000-5. PubMed ID: 25997988 [TBL] [Abstract][Full Text] [Related]
13. Atypical mucinous glandular proliferations in endometrial samplings: follow-up and other clinicopathological findings in 41 cases. Rawish KR; Desouki MM; Fadare O Hum Pathol; 2017 May; 63():53-62. PubMed ID: 28232161 [TBL] [Abstract][Full Text] [Related]
14. High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma. Ishikawa M; Nakayama K; Nakamura K; Ono R; Yamashita H; Ishibashi T; Minamoto T; Iida K; Razia S; Ishikawa N; Kyo S Hum Pathol; 2019 Mar; 85():92-100. PubMed ID: 30448219 [TBL] [Abstract][Full Text] [Related]
15. Papillary mucinous metaplasia of the endometrium as a possible precursor of endometrial mucinous adenocarcinoma. Yoo SH; Park BH; Choi J; Yoo J; Lee SW; Kim YM; Kim KR Mod Pathol; 2012 Nov; 25(11):1496-507. PubMed ID: 22766790 [TBL] [Abstract][Full Text] [Related]
16. PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors. Konopka B; Janiec-Jankowska A; Kwiatkowska E; Najmoła U; Bidziński M; Olszewski W; Goluda C Hum Pathol; 2011 Nov; 42(11):1710-9. PubMed ID: 21531001 [TBL] [Abstract][Full Text] [Related]
17. A Combined Morphologic and Molecular Approach to Retrospectively Identify KRAS-Mutated Mesonephric-like Adenocarcinomas of the Endometrium. Kolin DL; Costigan DC; Dong F; Nucci MR; Howitt BE Am J Surg Pathol; 2019 Mar; 43(3):389-398. PubMed ID: 30489318 [TBL] [Abstract][Full Text] [Related]
18. Emerging relationships between papillary proliferation of the endometrium and endometrial carcinoma: evidence from an immunohistochemical and molecular analysis. Liu Q; Wu Q; Yu M; Shi H; Lu B Virchows Arch; 2019 Aug; 475(2):201-209. PubMed ID: 31079233 [TBL] [Abstract][Full Text] [Related]
19. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia. Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295 [TBL] [Abstract][Full Text] [Related]